Monitoring multiple sclerosis: digital and fluid phase biomarkers

多发性硬化 医学 免疫学
作者
Kayla Ward,Stephen Reddel,Letizia Leocani,Michael Barnett
出处
期刊:Current Opinion in Neurology [Lippincott Williams & Wilkins]
卷期号:38 (3): 243-248 被引量:1
标识
DOI:10.1097/wco.0000000000001365
摘要

Purpose of review Monitoring of disease activity and treatment response in multiple sclerosis (MS) currently relies on the integration of qualitative clinical and radiological data that is of limited predictive value. An array of quantitative digital and fluid biomarkers, many on the cusp of broad clinical translation, is expected to herald a new era of data-driven therapeutic strategy, particularly with respect to the sequencing of disease-modifying therapies (DMTs). Available highly-effective DMTs, which largely abolish acute inflammatory activity in early, relapsing MS, have a limited impact on progressive MS disease biology. However, robust digital and fluid biomarkers of progression independent of relapse activity (PIRA) have emerged as a major unmet need, fuelled by the imminent availability of treatments that target pathomechanisms such as chronic active or smouldering brain inflammation. Recent findings The criteria for MS diagnosis incorporate both imaging and cerebrospinal fluid (CSF) biomarkers of the disease, which lacks a single diagnostic ‘test’. The recent validation of objective and quantitative CSF biomarkers, such as the k-FLC index, promises to improve diagnostic accuracy, particularly in patients with atypical or minor imaging changes. Precision monitoring of disease and is response to therapy is being transformed by the advent of clinically integrated, quantitative digital imaging tools; digital wearables and patient reported outcomes, including cognitive batteries delivered on personal devices; and an array of ultra-sensitive, readily-obtained serum fluid biomarkers that indicate the severity of tissue injury in MS. The promise of data-driven therapeutic strategy is being further explored in multimodal digital/fluid and digital twin biomarker studies that incorporate predictive artificial intelligence algorithms. Summary Here, we review the key near-term biomarkers that will guide individualised therapy for people with MS, targeting no evidence of disease activity (NEDA) in both early relapsing and established disease. In the medium term, composite digital and fluid biomarkers, integrated with clinical outcomes and underpinned by predictive artificial intelligence will have a transformative effect on the management of MS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
星辰咏发布了新的文献求助10
刚刚
李爱国的应助被科研通管家采纳,获得10
刚刚
愉快翠容完成签到 ,获得积分20
刚刚
乐乐的应助被科研通管家采纳,获得10
刚刚
脑洞疼的应助被科研通管家采纳,获得10
刚刚
领导范儿的应助被科研通管家采纳,获得10
刚刚
斯文败类的应助被科研通管家采纳,获得10
刚刚
leedada完成签到,获得积分20
刚刚
桐桐的应助被科研通管家采纳,获得10
1秒前
JamesPei的应助被科研通管家采纳,获得10
1秒前
1秒前
彭于晏的应助被科研通管家采纳,获得10
1秒前
领导范儿的应助被科研通管家采纳,获得10
1秒前
1秒前
1秒前
Owen的应助被科研通管家采纳,获得200
1秒前
桐桐的应助被科研通管家采纳,获得30
1秒前
CipherSage的应助被科研通管家采纳,获得10
1秒前
JamesPei的应助被科研通管家采纳,获得10
2秒前
了了发布了新的文献求助10
2秒前
Ray的应助被科研通管家采纳,获得10
2秒前
不带路的导航完成签到,获得积分10
2秒前
酷波er的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
Lucas的应助被科研通管家采纳,获得10
2秒前
丘比特的应助被科研通管家采纳,获得10
2秒前
zhonglv7的应助被科研通管家采纳,获得10
2秒前
鲸落小小的应助被科研通管家采纳,获得10
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
默默初阳的应助被科研通管家采纳,获得10
3秒前
3秒前
Owen的应助被科研通管家采纳,获得10
3秒前
情怀的应助被科研通管家采纳,获得10
3秒前
ndj发布了新的文献求助10
3秒前
3秒前
布丁仔完成签到,获得积分10
5秒前
5秒前
5秒前
大个的应助被多晒太阳采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182178
求助须知:如何正确求助?哪些是违规求助? 9571839
关于积分的说明 21820273
捐赠科研通 7778694
什么是DOI,文献DOI怎么找? 3433632
关于科研通互助平台的介绍 2557802
邀请新用户注册赠送积分活动 2479657